About BrainStorm

BrainStorm Cell Therapeutics (NASDAQ:BCLI) is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig’s disease), Multiple Sclerosis (MS) and Parkinson’s Disease (PD).

Learn More

Latest News

All News

Exploring Patient Access to NurOwn®

Brainstorm is exploring the possible commencement of a program to make NurOwn® available to a limited number of patients with Amyotrophic Lateral Sclerosis (ALS, also known as motor neuron disease) through a regulatory pathway designated for an orphan drug with a good safety profile and strong efficacy signals.  This program would potentially provide patients, who today face an unmet need, with access to this investigational treatment before it receives final marketing approval from the regulatory authorities.

Learn More